Response to Imatinib as a Function of Target Kinase Expression in Recurrent Glioblastoma

SpringerPlus - Germany
doi 10.1186/2193-1801-3-111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma

Clinical Medicine Insights: Oncology
Oncology
2015English

In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper Against Mitotic Catastrophe in Glioblastoma

Cancer Cell
Cancer ResearchOncologyCell Biology
2010English

Diacylglycerol Kinase Ζ Is a Target to Enhance NK Cell Function

Journal of Immunology
AllergyImmunology
2016English

Remarkable Response in a Case of Recurrent Gastrointestinal Stromal Tumor Treated With Low Dose Imatinib

Journal of Nihon University Medical Association
2016English

EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2005English

Pregnancy in a Patient With Recurrent Glioblastoma

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2013English

Protein Kinase C as a Therapeutic Target

Clinical Cancer Research
Cancer ResearchOncology
2006English

Response to MEK Inhibition With Trametinib and Tyrosine Kinase Inhibition With Imatinib in Multifocal Histiocytic Sarcoma

Haematologica
Hematology
2017English

Hitting the Target: Measuring EGFR Response to Tyrosine Kinase Inhibitors

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy